Kleo Pharmaceuticals Report issue

Foundation
Founded: New Haven CT United States (2017)
Status: Acquired by Biohaven Pharmaceuticals Inc. (2021) → now Pfizer (2022)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Kleo Pharmaceuticals

Active Ingredients

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Myeloma (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Overview

  • Highest Phase: None
  • # of Trials: 0
  • # of Trial APIs: 0